## **Core Concept**
Nuchal translucency (NT) is an ultrasound measurement used in early pregnancy to assess the risk of aneuploidy, particularly Down syndrome (Trisomy 21), and other chromosomal abnormalities. It involves measuring the thickness of the fluid-filled space at the back of the fetus's neck.

## **Why the Correct Answer is Right**
The correct answer, , is related to the use of nuchal translucency in screening for Down syndrome and other aneuploidies. The measurement of nuchal translucency between 11 and 14 weeks of gestation is a critical component of first-trimester screening for aneuploidy. An increased nuchal translucency thickness is associated with a higher risk of aneuploidy, congenital heart defects, and other fetal anomalies.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While ultrasound is used in various aspects of obstetric care, the specific term is not directly linked to nuchal translucency measurements.
- **Option B:** This option does not directly relate to the primary use of nuchal translucency measurements.
- **Option C:** Although congenital anomalies can be detected through ultrasound, this option does not specifically relate to the primary indication for nuchal translucency measurement.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that an increased nuchal translucency thickness warrants further investigation, including chorionic villus sampling (CVS) or amniocentesis, to determine the fetal karyotype. Additionally, a thickened nuchal fold later in pregnancy can be associated with an increased risk of aneuploidy and should prompt careful evaluation.

## **Correct Answer:** . Down syndrome screening.